Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)
Clinical calculations and diagnostic scoring systems like DAPT Score (Dual Antiplatelet Therapy Duration Post-PCI) frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.
What is the DAPT Score (Dual Antiplatelet Therapy Duration Post-PCI)?
The DAPT Score (Dual Antiplatelet Therapy Duration Post-PCI) is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in cardiology practice. Implements the validated ACC/AHA DAPT Study score to balance ischemic reduction against bleeding risk when deciding whether to extend dual antiplatelet therapy (DAPT) up to 30 months in post-PCI patients who have completed 12 uneventful months. Clinical scoring tools like DAPT Score (Dual Antiplatelet Therapy Duration Post-PCI) are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).
💡Clinical Pearls & Diagnostic Utility
Resolves the major clinical dilemma of whether to prolong blood thinners post-coronary stenting, maximizing cardiovascular protection while avoiding severe hemorrhagic complications.
Formula & Calculation Parameters
The mathematical equation and clinical variables required to calculate DAPT Score (Dual Antiplatelet Therapy Duration Post-PCI):
Score Interpretation & Clinical Stratification
| Score Range | Clinical Interpretation | Risk Tier |
|---|---|---|
| ≤ 1 | DAPT Score < 2: Standard 12-Month DAPT (Extend DAPT Not Recommended) | blue |
| ≥ 2 | DAPT Score ≥ 2: Extended DAPT Favorable (Continue up to 30 Months) | green |
When to Exercise Caution
Applies only to patients who have already completed 12 months of uneventful DAPT without major bleeding or recurrent ischemic events.
Clinical Review Board
Dr. Muhammad Nouman, MBBS
Capital Medical University | PMDC Reg No: 117744-P
Clinical Audit Status
✓ Verified for 2026 Guidelines
Last updated: 2026-08-08
Peer-Reviewed Medical Literature
- •Yeh RW, et al. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA. 2016;315(16):1735-1749.
- •Lawton JS, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. Circulation. 2022;145(3):e18-e114.
Related Cardiology Calculators & Scoring Tools
Explore related clinical calculators, risk stratification indexes, and diagnostic scoring algorithms in Cardiology:
Body Surface Area (BSA)
Calculate BSA using the Mosteller formula.
CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk
Calculates stroke risk for patients with atrial fibrillation.
HAS-BLED Score
Assesses bleeding risk in patients on anticoagulation therapy.
Ideal Body Weight (IBW)
Calculate ideal body weight using the Devine formula.
Mean Arterial Pressure (MAP)
Calculate MAP based on Systolic and Diastolic Blood Pressure.
HEART Score for Major Cardiac Events
Predicts 6-week risk of major adverse cardiac events (MACE).